Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis Antonis ValachisAndreas D. NearchouPehr Lind Review 25 February 2014 Pages: 443 - 455
Experiences and attitudes toward risk of recurrence testing in women with breast cancer: a systematic review Laura E. LeggettDiane L. LorenzettiFiona Clement Review 05 March 2014 Pages: 457 - 465
Breast cancer in Sub-Saharan Africa: opportunities for prevention Louise A. BrintonJonine D. FigueroaJoe Nat Clegg-Lamptey Review 07 March 2014 Pages: 467 - 478
Mammographic density—a review on the current understanding of its association with breast cancer C. W. HuoG. L. ChewE. W. Thompson Review 11 March 2014 Pages: 479 - 502
Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures Katherine Drews-ElgerJoeli A. BrinkmanDorraya El-Ashry Preclinical Study 25 February 2014 Pages: 503 - 517
SUMOylation proteins in breast cancer Alaa T. AlshareedaOla H. NegmEmad A. Rakha Preclinical study 01 March 2014 Pages: 519 - 530
Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ Malgorzata BanysMarkus HahnTanja Fehm Preclinical Study 04 March 2014 Pages: 531 - 538
Immune cell quantitation in normal breast tissue lobules with and without lobulitis Amy C. DegnimRushin D. BrahmbhattDaniel W. Visscher Preclinical study Open access 05 March 2014 Pages: 539 - 549
Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition Donald P. TaylorAmanda ClarkAlan Wells Preclinical study 09 March 2014 Pages: 551 - 560
Combined analysis of gene expression, DNA copy number, and mutation profiling data to display biological process anomalies in individual breast cancers Weiwei ShiBalint BalazsLajos Pusztai Preclinical study 12 March 2014 Pages: 561 - 568
Optimum duration of neoadjuvant letrozole to permit breast conserving surgery Robert CarpenterJulie C. DoughtyAnthony I. Skene Clinical Trial 23 February 2014 Pages: 569 - 576
Should we screen BRCA1 mutation carriers only with MRI? A multicenter study Inge-Marie ObdeijnGonneke A. O. Winter-WarnarsMadeleine M. A. Tilanus-Linthorst Clinical trial 25 February 2014 Pages: 577 - 582
31P magnetic resonance spectroscopy of the breast and the influence of the menstrual cycle B. L. StehouwerW. J. M. van der KempD. W. J. Klomp Clinical trial 26 February 2014 Pages: 583 - 589
Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103 Kathryn J. RuddyAnne O’NeillAnn H. Partridge Clinical trial 02 March 2014 Pages: 591 - 597
Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial Duveken B. Y. FonteinDaniel HoutsmaHenk-Jan Guchelaar Clinical Trial 04 March 2014 Pages: 599 - 606
The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation Pål MøllerAstrid StormorkenLovise Mæhle Clinical Trial Open access 12 March 2014 Pages: 607 - 614
A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events Christina L. AddisonNathaniel BouganimMark Clemons Clinical trial Open access 18 March 2014 Pages: 615 - 624
Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California Matthew P. BanegasLi TaoScarlett L. Gomez Epidemiology 28 February 2014 Pages: 625 - 634
Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history Peter Choon Eng KangSze Yee PhuahSoo Hwang Teo Epidemiology 01 March 2014 Pages: 635 - 642
Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer Timothy L. LashSoe Soe ThwinRebecca A. Silliman Epidemiology 01 March 2014 Pages: 643 - 663
Adjuvant chemotherapy dosing in low-income women: the impact of Hispanic ethnicity and patient self-efficacy Jennifer J. GriggsYihang LiuRose C. Maly Epidemiology 05 March 2014 Pages: 665 - 672
Early treatment discontinuation and switching in first-line metastatic breast cancer: the role of patient-reported symptom burden Mark S. WalkerAnthony S. MasaquelLee S. Schwartzberg Epidemiology 05 March 2014 Pages: 673 - 681
Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients Natalie PrinziEnke BaldiniSalvatore Ulisse Epidemiology 07 March 2014 Pages: 683 - 688
Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression Candyce H. KroenkeCarol SweeneyBette J. Caan Epidemiology 07 March 2014 Pages: 689 - 699